Phathom Pharmaceuticals Inc (PHAT) Implied Volatility Current

Tracking PHAT implied volatility helps you identify when options premiums on Phathom Pharmaceuticals Inc are historically cheap or expensive, and where the best trades are hiding. Phathom Pharmaceuticals Inc implied volatility reflects the market's expectation of future price movement: when PHAT IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Phathom Pharmaceuticals Inc's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For PHAT, tracking metrics like PHAT IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on PHAT signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also developing vonoprazan, which is in Phase III clinical trials for the treatment of erosive gastroesophageal reflux disease; and in combination with antibiotics for the treatment of Helicobacter pylori infection. Phathom Pharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Florham Park, New Jersey.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where PHAT implied volatility sits today versus where it has been. Our scanner ranks Phathom Pharmaceuticals Inc implied volatility against its historical range, surfaces extremes in PHAT IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Phathom Pharmaceuticals Inc IV is rich or cheap — measure it, then act on it.